Metagenomic next-generation sequencing for the etiological diagnosis of rabies virus in cerebrospinal fluid

Front Med (Lausanne). 2023 Feb 9:10:982290. doi: 10.3389/fmed.2023.982290. eCollection 2023.

Abstract

Background: Rabies is a highly fatal disease. Once symptoms develop, death usually occurs within days. Survivors were occasionally reported in the literatures. Ante-mortem diagnosis remains a challenge in most rabies endemic countries. A novel, accurate diagnostic assay is highly desirable.

Methods: We used metagenomic next-generation sequencing (mNGS) to examine the cerebrospinal fluid (CSF) samples of a 49-year-old patient with rabies and validated the results by TaqMan PCR and RT-PCR/Sanger sequencing.

Results: Metagenomic next-generation sequencing identified sequence reads uniquely aligned to the rabies virus (RABV). PCR confirmed the presence of the partial RABV N gene in the CSF. Phylogenetic analysis showed that the RABV grouped as an Asian clade, which is the most broadly distributed clade in China.

Conclusion: Metagenomic next-generation sequencing may be a useful screening tool for the etiological diagnosis of rabies, especially in the absence of timely rabies laboratory testing or in patients with no exposure history.

Keywords: cerebrospinal fluid; diagnosis; metagenomic next-generation sequencing; rabies; rabies virus.

Grants and funding

This study was supported by the National Key Research and Development Program of China (Grant no. 2021YFE0109000).